View Post

$3.8 Million Funds Houston Methodist's Chikungunya Vaccine Research

In COVID-19, Latest News by Precision Vaccinations

Scientists at the Houston Methodist Research Institute recently received $3.8 million to develop further a promising type of disease-defense technology that could pave the way for new 'circular RNA' vaccines.
The Coalition for Epidemic Preparedness Innovations (CEPI) announced on January 25, 2024, that it is teaming up with the Houston Methodist vaccinology team to advance its 'circRNA' vaccine development platform.

View Post

Confirming Measles Outbreaks By Wastewater Testing in 2024

In COVID-19, Latest News by Precision Vaccinations

Throughout January 2024, twenty-three measles cases have been detected in various United States cities, as the Centers for Disease Control and Prevention (CDC) reported last week.
In Philadelphia's outbreak, public health leaders used multiple tactics to identify nine measles cases.
Since the City of Philadelphia is already participating in a U.S. CDC poliovirus surveillance program, they could have leveraged that innovative system to identify measles virus hot spots.